Press Releases

Histobiolab Has Developed Professional Tissue Microarray to Meet Precise Research Needs

Creative Biogene Provides Reliable and High Quality Pseudovirus Services to Support The Studies of SARS-CoV-2

Qvirus Platform Designed Customized AAV Testing Services to Accelerate The Development of Viral Vaccine and Gene Therapy

Microbiosci Provides Comprehensive Service for Pichia Pastoris Fermentation to Process Development of Microbiological Research

CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects

Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research

Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.

Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment.

BioIVT Launches GMP Grade Human AB Serum to Facilitate the Development and Manufacturing of Cell and Gene Therapies

This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.

WuXi STA Launches its First Parenteral Formulation Manufacturing Line

CD ComputaBio Unveils Ligand-based Pharmacophore Model Service for Drug Design and Screening

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of ligand-based pharmacophore model service for scientists to accelerate the drug candidate development process.

Creative Proteomics Lipidomics Launches Exosomes Lipidomics Service to Study the Biological Characteristics of Vesicles

Lipidomics, a division of Creative Proteomics, is committed to providing untargeted lipidomics services, targeted lipidomics services, metabolic flux analysis services, and lipidomics related services for research institutions, biotechnology and pharmaceutical companies. The company continues to accelerate lipidomics research to make contributions in the fields of biopharmaceuticals, population health, the food industry, etc. Creative Proteomics Lipidomics has recently announced the launch of Exosomes Lipidomics Service, which can help scientists understand vesicle biogenesis and function, identify lipid-based biomarkers and unravel their monitoring function in diseases.

GutFlora Omics Platform Launches Virome Sequencing Service to Investigate Gut Microbiota

Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis

Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced Disease Cytokine Assays to help researchers obtain higher quality scientific research data.

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Indica Labs’ HALO AP® platform achieves CE-IVD certification for use in primary diagnosis

Indica Labs has announced that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm

Pharmaron Beijing Co., Limited, has announced today that it has acquired Aesica Pharmaceuticals Limited ("The Cramlington Site") from Recipharm group. This move will help Recipharm streamline operations in line with its strategic goals and better align with customers' needs.

Recipharm announces sale of Fontaine-lès-Dijon site to Astrea

Recipharm has today announced the sale of the solid dose manufacturing site at Fontaine-lès-Dijon, France, to Astrea Pharma. The move is a positive step in streamlining Recipharm's operations and consolidating its position as a top five global Contract Development and Manufacturing Organisation.

Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities

Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities Dokumeds brings complementary specialties and multinational footprint in Europe and beyond Research Triangle Park, NC – December 8, 2021 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced that it has acquired Dokumeds, a privately-held European CRO. Established in 1995 and headquartered in Riga, Latvia, Dokumeds has 10 offices and is active across multiple continents. Terms were not disclosed.